PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A10428 Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 90%

Allows mifepristone and misoprostol to be dispensed without patient or dispenser names/addresses on the label (with logs kept instead), making it easier to obtain medication abortion without the prescription label revealing the purpose or patient identity.

mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label, provided that such label includes a prescription number or other means of identifying the prescription.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2026-03-06: referred to higher education
Filed
2026-03-06
Committee
Higher Education
Sponsor
Karines Reyes D + 14 cosponsors (14 D)

Why the model tagged it this way: The bill amends education law to permit mifepristone and misoprostol (medication abortion drugs) to be dispensed without patient, prescriber, or dispenser names/addresses on the label, with logs or records kept instead and limited disclosure only for criminal investigations. This removes a labeling requirement that could identify the medication's purpose, expanding access to medication abortion by enhancing privacy.

Related bills

Sponsors

Text versions

History (1 actions)
DateChamberAction
2026-03-06Areferred to higher education